Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2005-05-10
2005-05-10
Scheiner, Laurie (Department: 1648)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S142100, C530S388300, C530S388150
Reexamination Certificate
active
06890532
ABSTRACT:
Human monoclonal rabies virus neutralizing antibodies represent a safe and efficacious post-exposure prophylactic therapy for individuals exposed to a rabies virus. The nucleic acid and encoded amino acid sequences of the heavy and light chain immunoglobulins of human monoclonal rabies virus neutralizing antibodies, and their use, is described.
REFERENCES:
patent: 239400 (1987-03-01), None
patent: 332424 (1989-03-01), None
patent: 338745 (1995-03-01), None
patent: WO 8909622 (1989-10-01), None
patent: WO 8909789 (1989-10-01), None
patent: WO 9321319 (1993-10-01), None
Morimoto et al., “Characterization Of A Unique Variant Of Bat Rabies Virus Responsible For Newly Emerging Human Cases In North America”,Proc. Natl. Acad. Sci. USA, vol. 93, pp. 5653-5658, (1996).
Dietzshold, B., “Techniques For The Purification Of Rabies Virus, Its Subunits And Recombinants Products,”Laboratory Techniques in Rabies, Meslin et al., (Eds.) World Health Organization, Geneva, pp. 175-180, (1996).
Plebanski, M. et al., “Primary And Secondary Human In Vitro T-Cell Responses To Soluble Antigens Are Mediated By Subsets Bearing Different CD45 Isoforms”,Immunology, vol. 75, pp. 86-91, (1992).
Hooper, D., “Rabies Virus”,Manual of Clinical Laboratory Immunology, Part II, 5thed., N.R. Rose (Ed.), ASM Press, Wash. D.C., pp. 755-760, (1997).
Pearson, W., et al., “Improved Tools For Biological Sequence Comparison”,Proc. Natl. Acad. Sci. USA, vol. 85, pp. 2444-2448, (1988).
Champion, J.M., et al., “The Development Of Monoclonal Human Rabies Virus-Neutralizing Antibodies As A Substitute For Pooled Human Immune Globulin In The Prophylactic Treatment Of Rabies Virus Exposure”,J. Immunological Methods, vol. 235, 81-90, (2000).
Pluckthun, A., “Antibody Engineering: Advances From The Use OfEscherichia ColiExpression Systems”,Bio/Technology, vol. 9, pp. 545-551, (1991).
Dietzschold, B., et al., “Biological Characterization Of Human Monoclonal Antibodies To Rabies Virus”,J. Virol., vol. 64, pp. 3087-3090, (1990).
Morimoto et al., Proc. Natl. Acad. Sci. USA, 93-5653 (1996).
Dietzschold, B., “Techniques for the purification of rabies virus, its subunits and recombinants products,” In:Laboratory Techniques in Rabies, Meslin et al., (Eds.) World Health Organization, Geneva, pp. 175-180 (1996).
Plebanski et al., Immunology, 75:86 (1992).
Hooper, D., “Rabies Virus,” In:Manual of Clinical Laboratory Immunology, Part II, 5thed., N.R. Rose (Ed.), ASM Press, Wash. D.C., pp. 755-760, (1997).
Pearson, et al., Proc. Natl. Acad. Sci. USA 85:2444-2448 (1988).
Champion, J.M., et al., J. Immunological Methods, 235:81-90, (2000).
Pluckthun, A., Bio/Technology 9:545-551 (1991).
Cheung, S.C., et al., J. Virol., 66:6714-6720 (1992).
Muller, B.H,, et al., J. Virol. Methods, 67:221-233 (1997).
Ikematsu, H. et al., J. Immunol., 150:1325-1338 (1993).
Rando, R.F., et al., Curr. Top. Microbiol. Immunol., 187:195-205 (1994).
Dietzschold, B., et al., J. Virol., 64:3087-3090 (1990).
Dietzschold Bernhard
Hooper Douglas C.
Drinker Biddle & Reath LLP
Scheiner Laurie
Thomas Jefferson University
LandOfFree
Rabies virus-specific neutralizing human monoclonal... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Rabies virus-specific neutralizing human monoclonal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rabies virus-specific neutralizing human monoclonal... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3405606